EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effectiveness of a Novel Low‐Density Lipoprotein Apheresis Device Rheocarna in Patients Undergoing Hemodialysis With Chronic Limb‐Threatening Ischemia: A Single‐Center Retrospective Study

Kunihiro Ishioka, Takayasu Ohtake, Kei Ohmori, Chika Shibuya, Tomoki Tsukahara, Mizuki Yamano, Yasuhiro Mochida, Machiko Oka, Kyoko Maesato, Yusuke Tsukamoto, Hidekazu Moriya, Sumi Hidaka und 1 weitere

Therapeutic Apheresis and Dialysis · 2026-08 · 30 (4) · 476-481

DOI: 10.1002/1744-9987.70164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, online erschienen am 22.06.2026. Verfasst von Kunihiro Ishioka und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Kidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kamakura, Japan. Hauptthemen laut MEDLINE: Renal Dialysis, Blood Component Removal, Lipoproteins, LDL, Ischemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic limb‐threatening ischemia (CLTI) is a severe form of lower‐extremity artery disease characterized by distal lesions and microcirculatory impairment, limiting revascularization efficacy. Rheocarna is a direct hemoperfusion low‐density lipoprotein (LDL) adsorption device with potential rheological and anti‐inflammatory benefits. The real‐world effectiveness of Rheocarna in patients with advanced CLTI undergoing hemodialysis (HD) remains unclear. This study evaluated clinical outcomes of Rheocarna therapy in patients with CLTI undergoing HD.

Methods

We retrospectively reviewed 31 patients undergoing HD (mean [±SD] age 67 ± 11 years) with CLTI treated with Rheocarna at a single center. Primary outcomes were ulcer healing at 6 months and amputation‐free survival (AFS) at 1 year, with baseline characteristics compared between healed and non‐healed groups.

Results

At 6 months, the ulcer healing, major amputation, and mortality rates were 25.8%, 35.5%, and 22.6%, respectively. The 1‐year AFS rate was 40%. The mean ankle–brachial index significantly improved from 1.00 ± 0.17 to 1.07 ± 0.15 ( p = 0.041).

Conclusion

Rheocarna may support wound healing and limb salvage in patients with CLTI undergoing HD; however, its clinical effectiveness appears limited in advanced disease stages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisBlood Component RemovalLipoproteins, LDLIschemiaChronic Limb-Threatening IschemiaHumansRetrospective StudiesFemaleMaleAgedAmputation, SurgicalTreatment OutcomeMiddle AgedWound HealingAnkle Brachial Index

Stichwörter der Autor:innen

LDL apheresisRheocarnaamputation‐free survivalchronic limb‐threatening ischemiahemodialysis

Substanzen

Lipoproteins, LDL

Autor:innen und Institutionen

  • Department of Nephrology, Kidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kamakura, Japan.

Zitieren

APA

Ishioka, K., Ohtake, T., Ohmori, K., Shibuya, C., Tsukahara, T., Yamano, M., Mochida, Y., Oka, M., Maesato, K., Tsukamoto, Y., Moriya, H., Hidaka, S., & Kobayashi, S. (2026). Effectiveness of a Novel Low‐Density Lipoprotein Apheresis Device Rheocarna in Patients Undergoing Hemodialysis With Chronic Limb‐Threatening Ischemia: A Single‐Center Retrospective Study. Therapeutic Apheresis and Dialysis, 30(4), 476-481. https://doi.org/10.1002/1744-9987.70164

Vancouver

Ishioka K, Ohtake T, Ohmori K, Shibuya C, Tsukahara T, Yamano M, et al. Effectiveness of a Novel Low‐Density Lipoprotein Apheresis Device Rheocarna in Patients Undergoing Hemodialysis With Chronic Limb‐Threatening Ischemia: A Single‐Center Retrospective Study. Therapeutic Apheresis and Dialysis. 2026;30(4):476-481. doi:10.1002/1744-9987.70164

BibTeX
@article{Ishioka2026,
  author = {Ishioka, Kunihiro and Ohtake, Takayasu and Ohmori, Kei and Shibuya, Chika and Tsukahara, Tomoki and Yamano, Mizuki and Mochida, Yasuhiro and Oka, Machiko and Maesato, Kyoko and Tsukamoto, Yusuke and Moriya, Hidekazu and Hidaka, Sumi and Kobayashi, Shuzo},
  title = {Effectiveness of a Novel Low‐Density Lipoprotein Apheresis Device Rheocarna in Patients Undergoing Hemodialysis With Chronic Limb‐Threatening Ischemia: A Single‐Center Retrospective Study},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2026},
  volume = {30},
  number = {4},
  pages = {476--481},
  doi = {10.1002/1744-9987.70164}
}
Kostenlos starten →